NewsSTAT
Ranked by formulaVerdict: RoutineCompass Pathways CEO: Psychedelics company will 'go slow before we go fast'
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared to "go slow before we go fast."
Score█████░░░░░5.1
VerdictCompetent work. Briefs at most.
Summary from the source
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared to “go slow before we go fast.”
The editor's rubric
| Dimension | Level | Weight | What that level means |
|---|---|---|---|
| Leverage | ██░░░ 2 | 15% | Reusable within one subfield (a technique, dataset, or protocol a few groups will adopt). |
| Magnitude | ██░░░ 2 | 20% | Solid incremental gain on a meaningful problem. |
| Evidence | ██░░░ 2 | 20% | Limited: single setting, weak baselines, or an observational association presented as causal. |
| Novelty | ██░░░ 2 | 10% | A new combination of known ideas. |
| Trajectory | ██░░░ 2 | 10% | Some room to improve with obvious engineering. |
| Stakes | ██░░░ 2 | 25% | Benefits a professional community (practitioners, clinicians, engineers). |
Editor’s rationale
Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: stakes (prevention or cure).
How the score was computed
Score█████░░░░░5.1
- Merit
- 3.4 / 10
- Adjusted merit
- 3.8 / 10
- Attention
- 28%
- Freshness
- 99%